eHealthObjects Chooses Elsevier/Gold Standard Drug Database for its HIE, EHR and Case & Disease Management Products

By Elsevier, PRNE
Sunday, May 1, 2011

TAMPA, Florida, May 2, 2011 - Leading drug database provider, Elsevier/Gold Standard,
( announced today that eHealthObjects, an
innovative healthcare solutions company, which specializes in delivering
healthcare technology products, solutions and platforms that can seamlessly
be integrated with other systems, has chosen Alchemy as its drug database.

Alchemy is a complete drug database best known for its
intelligent screening tools, which eliminate irrelevant and unnecessary
alerts. Designed so that all clinical decision support logic can be performed
in a single, instantaneous request, Alchemy works with any system
configuration, ensuring quick and simple installation and adoption.

"The superior technical architecture of Alchemy made it an
easy choice for us," said Sanjay Mittal, CEO for eHealthObjects. "Our mission
is to provide our clients with the highest quality content in the most
flexible format. Alchemy was the clear winner on both counts."

Alchemy will supply drug data to eHealthObject's ThinkHIE
(Health Information Exchange Platform), ThinkEHR (Inpatient and Ambulatory
Electronic Health Record) and ThinkCDM (Case and Disease Management)
products. These products and solutions are recognized by industry experts for
their interoperability and intuitive interfaces, which allow healthcare
providers and clinicians to become comfortable with them in just a few hours,
as opposed to weeks or months.

"We are delighted to provide drug data and decision support
for the eHealthObjects solutions," said Trygve Anderson, Vice President of
Product Management for Elsevier/Gold Standard. "Their dedication to
developing solutions that configure to the specific needs of their clients
aligns perfectly with the modern technical architecture of Alchemy, and we
share a mutual goal of providing the best data to be used as needed without
additional IT resources."

eHealthObjects has begun integrating Alchemy modules with its
systems and expects to offer its customers ThinkHIE, ThinkEHR and ThinkCDM,
including complete and automatically updating drug data, in May.

For more information on Alchemy for Elsevier/Gold Standard,
please contact Gold Standard at or 1-800-375-0943.

For more information on eHealthObjects and its products, please contact
eHealthObjects at: or 1-804-301-8555

Elsevier/Gold Standard

Based in Tampa, FL, Gold Standard/Elsevier uses innovative technologies
to provide a complete suite of drug information and decision support
solutions. With a tenacious commitment to product quality, Gold
Standard/Elsevier solutions empower healthcare organizations, professionals
and consumers to meet the most pressing healthcare challenges, improve
patient safety and ensure optimal outcomes. To learn more about Gold
Standard/Elsevier, visit


Based in Glen Allen, VA, eHealthObjects is a Healthcare products and
consulting company. The combination of its 3 core products -ThinkEHR,
ThinkHIE and ThinkCDM make eHealthObjects a unique company that offers a
complete end-to-end integrated solution to holistically record, manage and
exchange consumers' electronic health records using established care
management and ONC guidelines. For more information please visit

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet ( and Cell, ( and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect, ( SciVerse Scopus,
( Reaxys, ( MD
Consult ( and Nursing
Consult, ( which
enhance the productivity of science and health professionals, and the SciVal
suite ( and MEDai's Pinpoint Review, ( which help research and health care institutions
deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC, ( a world-leading publisher and
information provider, which is jointly owned by Reed Elsevier PLC and Reed
Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London
Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact

    Tom Reller
    VP, Global Corporate Relations


Biotechnology News

Elsevier News

will not be displayed